BioCentury
ARTICLE | Company News

AstraZeneca to use M&E Biotech screening technology

December 20, 2000 8:00 AM UTC

M&E Biotech (CSE:MEBIO) granted AZN non-exclusive access to its CellScreen technology that allows identification of validated targets by genetic manipulation of intracellular processes. MEBIO will rec...